IBDEI0GY ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,7633,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7633,1,3,0)
 ;;=3^Hyperlipidemia,Mixed
 ;;^UTILITY(U,$J,358.3,7633,1,4,0)
 ;;=4^E78.2
 ;;^UTILITY(U,$J,358.3,7633,2)
 ;;=^78424
 ;;^UTILITY(U,$J,358.3,7634,0)
 ;;=E78.5^^39^386^42
 ;;^UTILITY(U,$J,358.3,7634,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7634,1,3,0)
 ;;=3^Hyperlipidemia,Unspec
 ;;^UTILITY(U,$J,358.3,7634,1,4,0)
 ;;=4^E78.5
 ;;^UTILITY(U,$J,358.3,7634,2)
 ;;=^5002969
 ;;^UTILITY(U,$J,358.3,7635,0)
 ;;=E66.3^^39^386^59
 ;;^UTILITY(U,$J,358.3,7635,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7635,1,3,0)
 ;;=3^Overweight
 ;;^UTILITY(U,$J,358.3,7635,1,4,0)
 ;;=4^E66.3
 ;;^UTILITY(U,$J,358.3,7635,2)
 ;;=^5002830
 ;;^UTILITY(U,$J,358.3,7636,0)
 ;;=F17.200^^39^386^52
 ;;^UTILITY(U,$J,358.3,7636,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7636,1,3,0)
 ;;=3^Nicotine Dependence,Unspec
 ;;^UTILITY(U,$J,358.3,7636,1,4,0)
 ;;=4^F17.200
 ;;^UTILITY(U,$J,358.3,7636,2)
 ;;=^5003360
 ;;^UTILITY(U,$J,358.3,7637,0)
 ;;=G43.909^^39^386^50
 ;;^UTILITY(U,$J,358.3,7637,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7637,1,3,0)
 ;;=3^Migraine,Unspec
 ;;^UTILITY(U,$J,358.3,7637,1,4,0)
 ;;=4^G43.909
 ;;^UTILITY(U,$J,358.3,7637,2)
 ;;=^5003909
 ;;^UTILITY(U,$J,358.3,7638,0)
 ;;=H91.93^^39^386^36
 ;;^UTILITY(U,$J,358.3,7638,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7638,1,3,0)
 ;;=3^Hearing Loss,Bilateral
 ;;^UTILITY(U,$J,358.3,7638,1,4,0)
 ;;=4^H91.93
 ;;^UTILITY(U,$J,358.3,7638,2)
 ;;=^5006944
 ;;^UTILITY(U,$J,358.3,7639,0)
 ;;=I10.^^39^386^43
 ;;^UTILITY(U,$J,358.3,7639,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7639,1,3,0)
 ;;=3^Hypertension
 ;;^UTILITY(U,$J,358.3,7639,1,4,0)
 ;;=4^I10.
 ;;^UTILITY(U,$J,358.3,7639,2)
 ;;=^5007062
 ;;^UTILITY(U,$J,358.3,7640,0)
 ;;=I50.9^^39^386^19
 ;;^UTILITY(U,$J,358.3,7640,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7640,1,3,0)
 ;;=3^Congestive Heart Failure,Unspec
 ;;^UTILITY(U,$J,358.3,7640,1,4,0)
 ;;=4^I50.9
 ;;^UTILITY(U,$J,358.3,7640,2)
 ;;=^5007251
 ;;^UTILITY(U,$J,358.3,7641,0)
 ;;=I67.89^^39^386^18
 ;;^UTILITY(U,$J,358.3,7641,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7641,1,3,0)
 ;;=3^Cerebrovascular Disease,Oth
 ;;^UTILITY(U,$J,358.3,7641,1,4,0)
 ;;=4^I67.89
 ;;^UTILITY(U,$J,358.3,7641,2)
 ;;=^5007388
 ;;^UTILITY(U,$J,358.3,7642,0)
 ;;=J45.909^^39^386^4
 ;;^UTILITY(U,$J,358.3,7642,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7642,1,3,0)
 ;;=3^Asthma,Unspec,Uncomplicated
 ;;^UTILITY(U,$J,358.3,7642,1,4,0)
 ;;=4^J45.909
 ;;^UTILITY(U,$J,358.3,7642,2)
 ;;=^5008256
 ;;^UTILITY(U,$J,358.3,7643,0)
 ;;=J44.9^^39^386^16
 ;;^UTILITY(U,$J,358.3,7643,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7643,1,3,0)
 ;;=3^COPD,Unspec
 ;;^UTILITY(U,$J,358.3,7643,1,4,0)
 ;;=4^J44.9
 ;;^UTILITY(U,$J,358.3,7643,2)
 ;;=^5008241
 ;;^UTILITY(U,$J,358.3,7644,0)
 ;;=K21.9^^39^386^31
 ;;^UTILITY(U,$J,358.3,7644,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7644,1,3,0)
 ;;=3^GERD w/o Esophagitis
 ;;^UTILITY(U,$J,358.3,7644,1,4,0)
 ;;=4^K21.9
 ;;^UTILITY(U,$J,358.3,7644,2)
 ;;=^5008505
 ;;^UTILITY(U,$J,358.3,7645,0)
 ;;=N40.1^^39^386^29
 ;;^UTILITY(U,$J,358.3,7645,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7645,1,3,0)
 ;;=3^Enlarged Prostate w/ LUTS
 ;;^UTILITY(U,$J,358.3,7645,1,4,0)
 ;;=4^N40.1
 ;;^UTILITY(U,$J,358.3,7645,2)
 ;;=^5015690
 ;;^UTILITY(U,$J,358.3,7646,0)
 ;;=L03.818^^39^386^17
 ;;^UTILITY(U,$J,358.3,7646,1,0)
 ;;=^358.31IA^4^2
